Search

William A. Craigo

Examiner (ID: 17649, Phone: (571)270-1347 , Office: P/1615 )

Most Active Art Unit
1615
Art Unit(s)
1615
Total Applications
936
Issued Applications
383
Pending Applications
126
Abandoned Applications
445

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16310680 [patent_doc_number] => 20200289418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-17 [patent_title] => METHOD FOR INCREASING BIOAVAILABILITY OF NATURAL BIOACTIVE MOLECULES USING BIO-POLYMER COMPLEXATION TECHNOLOGY [patent_app_type] => utility [patent_app_number] => 16/817438 [patent_app_country] => US [patent_app_date] => 2020-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4858 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16817438 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/817438
METHOD FOR INCREASING BIOAVAILABILITY OF NATURAL BIOACTIVE MOLECULES USING BIO-POLYMER COMPLEXATION TECHNOLOGY Mar 11, 2020 Abandoned
Array ( [id] => 17625580 [patent_doc_number] => 20220160595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => AN ANTIPERSPIRANT COMPOSITION COMPRISING REACTIVE SALTS [patent_app_type] => utility [patent_app_number] => 17/432999 [patent_app_country] => US [patent_app_date] => 2020-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4782 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17432999 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/432999
AN ANTIPERSPIRANT COMPOSITION COMPRISING REACTIVE SALTS Mar 11, 2020 Abandoned
Array ( [id] => 17843666 [patent_doc_number] => 11433006 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-06 [patent_title] => Methods, compositions, and delivery systems for therapeutic skin treatments [patent_app_type] => utility [patent_app_number] => 16/800015 [patent_app_country] => US [patent_app_date] => 2020-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5963 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16800015 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/800015
Methods, compositions, and delivery systems for therapeutic skin treatments Feb 24, 2020 Issued
Array ( [id] => 20301265 [patent_doc_number] => 12447235 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-21 [patent_title] => Hydrogel hybrid material, method of its preparation and application [patent_app_type] => utility [patent_app_number] => 17/426629 [patent_app_country] => US [patent_app_date] => 2020-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 0 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17426629 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/426629
Hydrogel hybrid material, method of its preparation and application Feb 20, 2020 Issued
Array ( [id] => 15960417 [patent_doc_number] => 20200163960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-28 [patent_title] => INJECTABLE FORMULATION [patent_app_type] => utility [patent_app_number] => 16/775222 [patent_app_country] => US [patent_app_date] => 2020-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16368 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16775222 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/775222
INJECTABLE FORMULATION Jan 27, 2020 Abandoned
Array ( [id] => 17503438 [patent_doc_number] => 20220096540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-31 [patent_title] => PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF LYSOSOMAL STORAGE DISORDERS [patent_app_type] => utility [patent_app_number] => 17/310400 [patent_app_country] => US [patent_app_date] => 2020-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5405 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17310400 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/310400
Pharmaceutical composition for prevention or treatment of lysosomal storage disorders Jan 22, 2020 Issued
Array ( [id] => 16204924 [patent_doc_number] => 20200237914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-30 [patent_title] => Throat Lozenge [patent_app_type] => utility [patent_app_number] => 16/748758 [patent_app_country] => US [patent_app_date] => 2020-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2228 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16748758 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/748758
Throat Lozenge Jan 20, 2020 Abandoned
Array ( [id] => 17480466 [patent_doc_number] => 20220087970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => PREVENTION OF ANESTHETIC-INDUCED NEUROCOGNITIVE DYSFUNCTION [patent_app_type] => utility [patent_app_number] => 17/421497 [patent_app_country] => US [patent_app_date] => 2020-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26416 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17421497 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/421497
PREVENTION OF ANESTHETIC-INDUCED NEUROCOGNITIVE DYSFUNCTION Jan 17, 2020 Abandoned
Array ( [id] => 17472352 [patent_doc_number] => 20220079856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-17 [patent_title] => SUNSCREEN COSMETIC COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/423080 [patent_app_country] => US [patent_app_date] => 2020-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8530 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423080 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/423080
SUNSCREEN COSMETIC COMPOSITION Jan 7, 2020 Abandoned
Array ( [id] => 20127839 [patent_doc_number] => 12370139 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-29 [patent_title] => Use of edaravone in oral treatment of oxidative-stress mediated neurodegenerative disorders [patent_app_type] => utility [patent_app_number] => 16/733958 [patent_app_country] => US [patent_app_date] => 2020-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 423 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16733958 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/733958
Use of edaravone in oral treatment of oxidative-stress mediated neurodegenerative disorders Jan 2, 2020 Issued
Array ( [id] => 17618881 [patent_doc_number] => 11337906 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-24 [patent_title] => Hair care and conditioning compositions [patent_app_type] => utility [patent_app_number] => 16/731654 [patent_app_country] => US [patent_app_date] => 2019-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17412 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16731654 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/731654
Hair care and conditioning compositions Dec 30, 2019 Issued
Array ( [id] => 17355199 [patent_doc_number] => 20220015995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => AEROSOL FOAM DEVICE CONTAINING A COMPOSITION RICH IN FATTY SUBSTANCES [patent_app_type] => utility [patent_app_number] => 17/311288 [patent_app_country] => US [patent_app_date] => 2019-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5506 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17311288 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/311288
AEROSOL FOAM DEVICE CONTAINING A COMPOSITION RICH IN FATTY SUBSTANCES Dec 18, 2019 Abandoned
Array ( [id] => 16663921 [patent_doc_number] => 10933143 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-02 [patent_title] => Modified release formulations containing drug-ion exchange resin complexes [patent_app_type] => utility [patent_app_number] => 16/719121 [patent_app_country] => US [patent_app_date] => 2019-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19051 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16719121 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/719121
Modified release formulations containing drug-ion exchange resin complexes Dec 17, 2019 Issued
Array ( [id] => 17480533 [patent_doc_number] => 20220088037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => A SUSTAINED RELEASE COMPOSITION COMPRISING A HYDROXYALKYL METHYLCELLULOSE [patent_app_type] => utility [patent_app_number] => 17/312417 [patent_app_country] => US [patent_app_date] => 2019-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9347 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17312417 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/312417
A SUSTAINED RELEASE COMPOSITION COMPRISING A HYDROXYALKYL METHYLCELLULOSE Dec 16, 2019 Abandoned
Array ( [id] => 16428218 [patent_doc_number] => 10828278 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-10 [patent_title] => Tesofensine and beta blocker combination formulations [patent_app_type] => utility [patent_app_number] => 16/705370 [patent_app_country] => US [patent_app_date] => 2019-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 13250 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16705370 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/705370
Tesofensine and beta blocker combination formulations Dec 5, 2019 Issued
Array ( [id] => 16204680 [patent_doc_number] => 20200237670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-30 [patent_title] => DYE-STABILIZED NANOPARTICLES AND METHODS OF THEIR MANUFACTURE AND THERAPEUTIC USE [patent_app_type] => utility [patent_app_number] => 16/698572 [patent_app_country] => US [patent_app_date] => 2019-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18255 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16698572 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/698572
DYE-STABILIZED NANOPARTICLES AND METHODS OF THEIR MANUFACTURE AND THERAPEUTIC USE Nov 26, 2019 Abandoned
Array ( [id] => 16853549 [patent_doc_number] => 20210154294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-27 [patent_title] => ELIMINATION OF EXOTIC PATHOGENS [patent_app_type] => utility [patent_app_number] => 16/698189 [patent_app_country] => US [patent_app_date] => 2019-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12310 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16698189 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/698189
ELIMINATION OF EXOTIC PATHOGENS Nov 26, 2019 Abandoned
Array ( [id] => 16491097 [patent_doc_number] => 10857115 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-08 [patent_title] => Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug [patent_app_type] => utility [patent_app_number] => 16/696583 [patent_app_country] => US [patent_app_date] => 2019-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5928 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16696583 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/696583
Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug Nov 25, 2019 Issued
Array ( [id] => 17103101 [patent_doc_number] => 11123289 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-09-21 [patent_title] => Rapamycin for the treatment of lymphangioleiomyomatosis [patent_app_type] => utility [patent_app_number] => 16/695895 [patent_app_country] => US [patent_app_date] => 2019-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21863 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16695895 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/695895
Rapamycin for the treatment of lymphangioleiomyomatosis Nov 25, 2019 Issued
Array ( [id] => 17249872 [patent_doc_number] => 11185336 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-30 [patent_title] => Embolization device constructed from expansile polymer [patent_app_type] => utility [patent_app_number] => 16/678978 [patent_app_country] => US [patent_app_date] => 2019-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9183 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16678978 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/678978
Embolization device constructed from expansile polymer Nov 7, 2019 Issued
Menu